{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiaz7x7rkh56bw723hknouzlrxo7gd5n7gsypn6iggnos3cpocarni",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhiajido5oa2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreianlrvy42bbnxmnsui572ab2oucobac52ytwmo73dv3v4yzulmuju"
    },
    "mimeType": "image/jpeg",
    "size": 76048
  },
  "path": "/2026/03/20/novartis-acquires-synnovation-breast-cancer-drug-snv4818/?utm_campaign=rss",
  "publishedAt": "2026-03-20T08:22:25.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Cancer",
    "drug development",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "Looking to bolster its pipeline, Novartis is buying a breast cancer drug candidate for $2 billion from Delaware-based Synnovation Therapeutics.",
  "title": "STAT+: Novartis picks up experimental breast cancer drug for $2B",
  "updatedAt": "2026-03-20T08:22:28.000Z"
}